Timothy P. Murphy, M.D. spent 25 years as an Interventional Radiologist and clinical trialist achieving the rank of Full Professor, Research Track, at Alpert School of Medicine at Brown University. He is a Past President of the Society of lnterventional Radiology (SIR) and recipient of the Charles T. Dotter Award in 2018. He served in leadership roles of three NIH-sponsored vascular disease clinical trials (CORAL, CLEVER, and ATTRACT), and has published over 200 journal articles and given more than 185 presentations all over the world. Dr. Murphy joined Summa full time in 2018. In his more than 25 years training fellows at Brown University Dr. Murphy would impress on trainees the importance of eliminating unnecessary steps. That informs his approach to medical device design. Dr. Murphy believes that ergonomic medical device design is crucial for enhancing user experience, reducing strain, and improving efficiency and patient outcomes. Summa Therapeutics is a commercial-stage company currently field testing its FDA-cleared novel injectable angioplasty balloon catheter, and evaluating its ability to simplify complex peripheral revascularization procedures among patients at risk for amputation due to arterial insufficiency. Curriculum Vitae